top of page

Five common misconceptions about Electronic Prescribing for Controlled Substances

Jul 7, 2020

Struggling with the DEA Requirements for EPCS?

There are a number of complexities to the DEA interim final rule (IFR) that organizations must work through to become EPCS compliant. These complexities have led to misconceptions about how to reach compliancy and which processes, authentication protocols and technologies are fully DEA compliant.

In this whitepaper, you will learn:

  • 5 common misconceptions of Electronic Prescribing of Controlled Substances (EPCS)

  • The debunking of the misconceptions

  • The technologies that are fully compliant with the DEA requirements for EPCS

Related resources

May 21, 2024

How Imprivata helps customers meet cyber insurance requirements

Whitepapers

May 20, 2024

Trust in Depth - The Comprehensive Approach to Data Privacy

Whitepapers

May 15, 2023

Electronic Prescribing of Controlled Substances: establishing a secure, auditable chain of trust

Whitepapers

bottom of page